# Rechallenge for Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rechallenge-for-patients-with-i-ras-i-and-i-braf-i-wild-type-metastatic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Chiara Cremolini,Daniele Rossini,Emanuela Dell’Aquila,Sara Lonardi,Elena Conca,Marzia Del Re,Adele Busico,Filippo Pietrantonio,Romano Danesi,Giuseppe Aprile,Emiliano Tamburini,Carlo Barone,Gianluca Masi,Francesco Pantano,Francesca Pucci,Domenico Corsi,Nicoletta Pella,Francesca Bergamo,Eleonora Rofi,C. Barbara,Alfredo Falcone,Daniele Santini |
| Citations | 423 |
| DOI | 10.1001/jamaoncol.2018.5080 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://jamanetwork.com/journals/jamaoncology/articlepdf/2716075/jamaoncology_cremolini_2018_oi_180093.pdf |
| OpenAlex ID | https://openalex.org/W2901178367 |
| PMID | 30476968 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Romano Danesi](https://scholariq.org/researchers/romano-danesi/)
- [Marzia Del Re](https://scholariq.org/researchers/marzia-del-re/)
- [Sara Lonardi](https://scholariq.org/researchers/sara-lonardi/)

## Paper journal

- [JAMA Oncology](https://scholariq.org/journals/jama-oncology/)

## Paper primary topic

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Paper topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Cells and Metastasis](https://scholariq.org/topics/cancer-cells-and-metastasis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
